News

Drug Delivery Business10h
Tandem Diabetes Care posts Q2 sales beat, expects $1B in revenue for 2025
(Nasdaq:TNDM) shares fell after hours today on second-quarter results that topped the consensus sales forecast.
Drug Delivery Business9h
Senseonics posts Street-beating Q2 with 37% sales growth
Senseonics (NYSE:SENS) shares remained relatively unmoved today on second-quarter results that beat the consensus sales ...
Drug Delivery Business14h
MannKind submits inhaled insulin to FDA for pediatrics, inks $500M financing agreement with Blackstone
The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...